symproic
Generic: NALDEMEDINE TOSYLATE
symproic: sourced relationships with 1 company · 1 FDA decision.
symproic evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect symproic to BDSI; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could symproic → BDSI affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Treatment of opioid-induced constipation in adult patients with chronic non-cancer pain
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL INC (BDSI) Treatment of opioid-induced constipation in adult patients w… | Approved |
Frequently asked questions
Which companies have sourced relationships with symproic?
symproic has dated SEC/FDA relationship records for BIODELIVERY SCIENCES INTERNATIONAL INC.
What is symproic's latest FDA decision?
The most recent tracked FDA decision for symproic is Approval, dated March 23, 2017.